HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lixin Jiang Selected Research

Antihypertensive Agents (Antihypertensives)

7/2018Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study.
12/2017Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
12/2017Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lixin Jiang Research Topics

Disease

27Neoplasms (Cancer)
01/2024 - 06/2008
18Myocardial Infarction
11/2019 - 11/2009
11Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 03/2014
7Hemorrhage
11/2019 - 11/2009
7ST Elevation Myocardial Infarction
11/2019 - 02/2016
6Stroke (Strokes)
11/2019 - 11/2009
5Stomach Neoplasms (Stomach Cancer)
12/2022 - 06/2015
5Hypertension (High Blood Pressure)
07/2018 - 01/2017
4Carcinogenesis
01/2023 - 06/2015
4Neoplasm Metastasis (Metastasis)
03/2021 - 01/2015
4Papillary Thyroid Cancer
08/2018 - 04/2016
4Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2015
4Thyroid Neoplasms (Thyroid Cancer)
12/2017 - 04/2016
3Breast Neoplasms (Breast Cancer)
12/2023 - 01/2015
3Adenocarcinoma
01/2021 - 06/2015
3Coronary Disease (Coronary Heart Disease)
01/2018 - 06/2011
3Coronary Artery Disease (Coronary Atherosclerosis)
11/2016 - 01/2014
2Tendinopathy (Tendonitis)
12/2023 - 12/2023
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2023 - 10/2017
2Diabetes Mellitus
09/2022 - 12/2017
2Ischemia
11/2019 - 01/2012
2Albuminuria
01/2018 - 01/2017
2Chronic Renal Insufficiency
01/2018 - 06/2011
2Lymphatic Metastasis
09/2017 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 12/2016
2Cardiogenic Shock
09/2015 - 10/2014
2Acute Coronary Syndrome
09/2014 - 01/2012
2Hypoxia (Hypoxemia)
11/2008 - 06/2008
1Aggressive Fibromatosis (Desmoid)
01/2024
1Triple Negative Breast Neoplasms
11/2023
1Pathologic Complete Response
07/2023
1Epilepsy (Aura)
01/2023
1Neuroblastoma
03/2022
1Flatulence
01/2022
1Transient Ischemic Attack
11/2019
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
12/2018
1Thyroid Nodule (Nodule, Thyroid)
08/2018
1Hyperthermia
05/2018
1Dyslipidemias (Dyslipidemia)
01/2018

Drug/Important Bio-Agent (IBA)

5Messenger RNA (mRNA)IBA
01/2021 - 05/2010
5Clopidogrel (Plavix)FDA Link
11/2019 - 11/2009
5Biomarkers (Surrogate Marker)IBA
10/2017 - 01/2015
4Long Noncoding RNAIBA
01/2023 - 04/2016
4LDL CholesterolIBA
01/2019 - 06/2011
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2016 - 06/2011
3TicagrelorIBA
11/2019 - 01/2018
3Thyrotropin Receptors (Thyrotropin Receptor)IBA
08/2018 - 04/2016
3Antihypertensive Agents (Antihypertensives)IBA
07/2018 - 12/2017
3MicroRNAs (MicroRNA)IBA
06/2015 - 01/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 06/2015
2Contrast MediaIBA
01/2022 - 01/2022
2Cyclin D1IBA
08/2018 - 04/2016
2Proteins (Proteins, Gene)FDA Link
01/2017 - 11/2016
2Cyclophilin AIBA
01/2017 - 12/2016
2Bevacizumab (Avastin)FDA Link
01/2017 - 03/2016
2Cyclophilins (Cyclophilin)IBA
01/2017 - 12/2016
2Mitogen-Activated Protein KinasesIBA
04/2016 - 04/2016
2Thrombin Receptors (Thrombin Receptor)IBA
09/2014 - 01/2012
2vorapaxarIBA
09/2014 - 01/2012
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2010 - 11/2009
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2008 - 06/2008
1Small Cytoplasmic RNAIBA
12/2023
1RNA (Ribonucleic Acid)IBA
12/2023
1salicylhydroxamic acid (SHAM)IBA
12/2023
1Dinoprostone (PGE2)FDA Link
12/2023
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
11/2023
1GoldIBA
11/2023
1NanocapsulesIBA
11/2023
1CY5.5 cyanine dyeIBA
01/2023
1MagnesiumIBA
01/2023
1perflubron (L 1913)FDA Link
01/2023
1ArsenicIBA
03/2022
1histidine-rich proteinsIBA
03/2021
11-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
12/2019
1polyethylene glycol polyethyleneimine nanogelIBA
11/2019
1oxidized low density lipoproteinIBA
01/2019
1LDL Receptors (LDL Receptor)IBA
01/2019
1glycolic acid (glycolate)IBA
05/2018
1Blood Glucose (Blood Sugar)IBA
01/2018

Therapy/Procedure

25Therapeutics
12/2023 - 04/2006
6Percutaneous Coronary Intervention
12/2018 - 03/2014
5Thrombolytic Therapy
11/2019 - 10/2016
4Secondary Prevention
12/2017 - 09/2015
3Drug Therapy (Chemotherapy)
11/2023 - 04/2016
3Extracorporeal Shockwave Therapy
01/2020 - 04/2014
2Neoadjuvant Therapy
12/2023 - 07/2023
2Injections
12/2023 - 11/2008
2Precision Medicine
11/2023 - 11/2019
2Gastrectomy
09/2022 - 09/2017
2Length of Stay
01/2022 - 01/2015
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2016 - 02/2016
2Contraindications
09/2015 - 02/2015
2Patient Readmission
09/2014 - 01/2012
1High-Intensity Focused Ultrasound Ablation
01/2024
1Lymph Node Excision (Lymph Node Dissection)
12/2022
1Blood Transfusion (Blood Transfusions)
09/2022
1Enhanced Recovery After Surgery
05/2020
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2018